The two IBEC-led CIBER-BBN tissue regeneration projects that were earmarked for funding by the EU’s ERA-NET EuroNanoMed initiative last year (see www.ibecbarcelona.eu/IBEC-News/funding-success-for-two-ibec-projects.html) have both received the national support they need to get started.
‘Nanostructured Gel for Cellular Therapy of Degenerative Skeletal Disorders’ (STRUCTGEL), coordinated by Molecular Dynamics at Cell-biomaterial Interface group leader George Altankov, had its kick-off meeting last Friday 3 February. The partners from Spain, Germany, France and Turkey will tackle degenerative skeletal tissue disorders such as osteoarthritis by designing an implant able to influence site-specific tissue regeneration.
‘Angiogenic nanostructured materials for non-consolidating bone fractures’ (nAngioFrac), coordinated by Josep Planell’s Biomaterials for Regenerative Therapies group at IBEC, brings together partners from Spain, France and Poland. It aims to develop tailored biodegradable and bioactive nanostructured scaffolds to ensure the correct release of calcium to promote tissue repair in pseudarthrosis, a condition which results from inadequate healing after a bone fracture and sometimes during development, resulting in a ‘false joint’. Its kick-off meeting will take place on 17 February.